Jayson Bedford
Stock Analyst at Raymond James
(3.83)
# 702
Out of 5,115 analysts
324
Total ratings
54.72%
Success rate
7.55%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Outperform | $20 → $27 | $32.64 | -17.28% | 2 | Oct 30, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $577.15 | +4.48% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $21.46 | -11.46% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $124.81 | +16.98% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $207.78 | +0.59% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $90.23 | +25.24% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $146.98 | +22.47% | 22 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $87.45 | +16.64% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $67.42 | +51.29% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $96.13 | +28.99% | 26 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $328 → $360 | $288.82 | +24.65% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $204 → $185 | $133.28 | +38.81% | 7 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $196.12 | +37.67% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $13.17 | -24.07% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $122.33 | +121.53% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $19.29 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $22.48 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $86.29 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $19.11 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $97.27 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $6.05 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $74.50 | +15.44% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.59 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $12.66 | - | 3 | Jan 2, 2018 |
Axogen
Oct 30, 2025
Maintains: Outperform
Price Target: $20 → $27
Current: $32.64
Upside: -17.28%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $577.15
Upside: +4.48%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $21.46
Upside: -11.46%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $124.81
Upside: +16.98%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $207.78
Upside: +0.59%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $90.23
Upside: +25.24%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $146.98
Upside: +22.47%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $87.45
Upside: +16.64%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $67.42
Upside: +51.29%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $96.13
Upside: +28.99%
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $288.82
Upside: +24.65%
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $133.28
Upside: +38.81%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $196.12
Upside: +37.67%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $13.17
Upside: -24.07%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $122.33
Upside: +121.53%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $19.29
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $22.48
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $86.29
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $19.11
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $97.27
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $6.05
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $74.50
Upside: +15.44%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $2.59
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $12.66
Upside: -